Boston Scientific Corp. (BSX)
43.12
+0.39
(+0.91%)
USD |
NYSE |
Oct 12, 13:21
Boston Scientific Free Cash Flow (Quarterly) : 1.279B for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.279B |
| March 31, 2026 | 171.00M |
| December 31, 2025 | 1.013B |
| September 30, 2025 | 1.162B |
| June 30, 2025 | 1.129B |
| March 31, 2025 | 354.00M |
| December 31, 2024 | 1.179B |
| September 30, 2024 | 823.00M |
| June 30, 2024 | 658.00M |
| March 31, 2024 | -15.00M |
| December 31, 2023 | 690.00M |
| September 30, 2023 | 508.00M |
| June 30, 2023 | 515.00M |
| March 31, 2023 | 79.00M |
| December 31, 2022 | 595.00M |
| September 30, 2022 | 321.00M |
| June 30, 2022 | 201.00M |
| March 31, 2022 | -179.00M |
| December 31, 2021 | 212.00M |
| September 30, 2021 | 360.00M |
| June 30, 2021 | 536.00M |
| March 31, 2021 | 209.00M |
| December 31, 2020 | 514.00M |
| September 30, 2020 | 594.00M |
| June 30, 2020 | 201.00M |
| Date | Value |
|---|---|
| March 31, 2020 | -177.00M |
| December 31, 2019 | 506.00M |
| September 30, 2019 | 381.00M |
| June 30, 2019 | 201.00M |
| March 31, 2019 | 287.00M |
| December 31, 2018 | -87.00M |
| September 30, 2018 | 425.00M |
| June 30, 2018 | -477.00M |
| March 31, 2018 | 133.00M |
| December 31, 2017 | 793.00M |
| September 30, 2017 | 204.00M |
| June 30, 2017 | 108.00M |
| March 31, 2017 | 2.00M |
| December 31, 2016 | 299.00M |
| September 30, 2016 | -102.00M |
| June 30, 2016 | 343.00M |
| March 31, 2016 | 56.00M |
| December 31, 2015 | 244.00M |
| September 30, 2015 | 338.00M |
| June 30, 2015 | 14.00M |
| March 31, 2015 | -243.00M |
| December 31, 2014 | 361.00M |
| September 30, 2014 | 290.00M |
| June 30, 2014 | 220.00M |
| March 31, 2014 | 139.00M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Abbott Laboratories | 1.991B |
| Becton, Dickinson & Co. | 509.00M |
| Intuitive Surgical, Inc. | 948.40M |
| Stryker Corp. | 1.059B |
| Insulet Corp. | 51.20M |